NAA15 antibody (N-Term)
-
- Target See all NAA15 Antibodies
- NAA15 (N(alpha)-Acetyltransferase 15, NatA Auxiliary Subunit (NAA15))
-
Binding Specificity
- N-Term
-
Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This NAA15 antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- NARG1 antibody was raised against the N terminal of NARG1
- Purification
- Affinity purified
- Immunogen
- NARG1 antibody was raised using the N terminal of NARG1 corresponding to a region with amino acids LRPAQRASWIGYAIAYHLLEDYEMAAKILEEFRKTQQTSPDKVDYEYSEL
- Top Product
- Discover our top product NAA15 Primary Antibody
-
-
- Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
NARG1 Blocking Peptide, catalog no. 33R-5374, is also available for use as a blocking control in assays to test for specificity of this NARG1 antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NARG1 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- NAA15 (N(alpha)-Acetyltransferase 15, NatA Auxiliary Subunit (NAA15))
- Alternative Name
- NARG1 (NAA15 Products)
- Synonyms
- Ga19 antibody, NARG1 antibody, NATH antibody, TBDN100 antibody, 5730450D16Rik antibody, 6330400I15 antibody, ASTBDN antibody, Narg1 antibody, Tbdn-1 antibody, mNAT1 antibody, narg1l antibody, N(alpha)-acetyltransferase 15, NatA auxiliary subunit antibody, N(alpha)-acetyltransferase 15, NatA auxiliary subunit S homeolog antibody, NAA15 antibody, Naa15 antibody, naa15.S antibody
- Background
- The ARD1A-NARG1 complex displays alpha (N-terminal) acetyltransferase activity that may be important for vascular, hematopoietic and neuronal growth and development. NARG1 is required to control retinal neovascularization in adult ocular endothelial cells. In complex with G22P1 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter.
- Molecular Weight
- 101 kDa (MW of target protein)
-